Stocks in Focus

First Trading Day After Stock Split… MOA Life Plus Hits 'Daily Price Limit' [Featured Stock]

Kwon Oh Seok
2026-08-31 09:36:25
[Edaily Reporter Kwon Oh Seok ] MOA Life Plus(142760), a global beauty and health company, soared to its daily price limit on the 31st, its first trading day following a stock consolidation.
(Photo courtesy of MOA Life Plus)

According to MP Doctor on that day, MOA Life Plus is trading at 907 won, the daily upper limit, up 29.94% from the previous trading day.
Previously, MOA Life Plus had suspended trading from the 7th to the 28th to consolidate its par value from 500 won to 1,000 won. The company explained the purpose of the par value consolidation as “stabilizing the stock price and enhancing corporate value by maintaining an appropriate number of shares in circulation.”

Economy

Corporation

IT·Science

Economy

Shifting from Short-Term to Medium- and Long-Term... Appeal of Commercial Paper as a Funding Source Plummets

Fluctuations in credit spreads serve as an indicator of investor sentiment and capital flows in the corporate bond market. “Credit Signal” provides an intuitive analysis of the market’s overall trends…
2026-10-23 17:57:04

Corporation

SCL Science Takes on Liver and Ovarian Cancer Vaccines… Aims to File IND Application Next Year [Invest Bio]

SCL Science(246960)is accelerating its new drug development efforts, spearheaded by vaccines for liver and ovarian cancer. With the goal of submitting an Investigational New Drug (IND) application nex…
2026-10-24 06:01:03

IT·Science

HANALL BIOPHARMA CO.,LTD’s ‘Batoclimab’ Receives First New Drug Approval in China Nine Years After Technology Export

“Batoclimab,” a treatment for autoimmune diseases developed by HANALL BIOPHARMA CO.,LTD(009420), has received new drug approval in China. This comes approximately nine years after the company licensed…
2026-10-23 21:05:02